You are here: Industry Insights > brain tumor

News List

Moleculin Announces Positive Interim Results in Adult Glioblastoma Clinical Trial americanpharmaceuticalreview
October 19, 2020
Moleculin Biotech announced additional preliminary data from the Phase 1 clinical trial of its immuno-stimulating STAT3 inhibitor, WP1066, in patients with glioblastoma (GBM).
MediciNova Receives Notice of Allowance for Second Patent Covering Glioblastoma Treatment americanpharmaceuticalreview
April 24, 2020
MediciNova has received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application which covers MN-166 (ibudilast) for the treatment of glioblastoma.
Laser-Based Imaging + AI May Diagnose Brain Tumors in OR drugs
January 07, 2020
A novel workflow that combines advanced optical imaging with an artificial intelligence algorithm may accurately diagnose brain tumors in real time in the operating room, according to a study published online Jan. 6 in Nature Medicine.
This gene mutation is key to glioblastoma’s ‘immortality’ and could point to drug targets fiercebiotech
September 11, 2018
Glioblastoma, the brain cancer that took the life of Sen. John McCain, has proven especially difficult to target with drugs.
Childhood Brain Tumor Treatment May Hamper Adult Survivors drugs
August 10, 2018
More than half of adults who survived childhood brain and spinal cord cancers don't live fully independent lives, a new study finds.
Mayo Clinic Gets Brain Tumor Research Grant americanpharmaceuticalreview
May 04, 2017
Mayo Clinic and the Massachusetts Institute of Technology (MIT) have been awarded a joint five-year, $9.7 million grant from the National Cancer Institute (NCI) to support a physical sciences-oncology center.
INSIGHTEC: First Patient with Benign Brain Tumor has Focused Ultrasound Procedure at Nicklaus Childr en-cphi.cn
April 24, 2017
INSIGHTEC congratulates Nicklaus Children's Hospital for performing the first focused ultrasound procedure on a 21-year old patient suffering seizures associated with a benign hypothalamic hamartoma brain tumor.
Study reveals promising new strategy to attack deadly pediatric brain tumor news-medical.net
March 08, 2017
Researchers from Northwestern Medicine and Ann & Robert H. Lurie Children's Hospital of Chicago have revealed new insight into how the most deadly pediatric brain tumor, diffuse intrinsic pontine glioma (DIPG), may develop.
Molecule stops fatal pediatric brain tumor worldpharmanews
March 01, 2017
The scientists have found a molecule that stops the growth of an aggressive pediatric brain tumor. The tumor is always fatal and primarily strikes children under 10 years old.